Monacolins from red yeast rice
European Union
Jun 13, 2022
Commission Regulation (EU) 2022/860 of 1 June 2022 amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards monacolins from red yeast-fermented rice has been published.
Annex III to Regulation (EC) No 1925/2006 is amended as follows:
Restricted substance |
Conditions of use |
Additional requirements |
‘Monacolins from red yeast rice |
Individual portion of the product for daily consumption shall provide less than 3 mg of monacolins from red yeast rice. |
The label shall provide the number of individual portions of the product for maximum daily consumption and a warning not to consume a daily amount of 3 mg of monacolins from red yeast rice or more. The label shall indicate the content of monacolins per portion of the product. The label shall include the following warnings: “Should not be consumed by pregnant or lactating women, children below 18 years old and adults above 70 years old”. “Seek advice from a doctor on consumption of this product if you experience any health problems”; “Should not be consumed if you are taking cholesterol-lowering medication”; “Should not be consumed if you are already consuming other products containing red yeast rice”.’ |
For further information (in English), click on the Link